<p>Michael W. Dunne, Director at Iterum Therapeutics plc, has reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-288848), on November 20, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ITRM

<p>Michael W. Dunne, Director at Iterum Therapeutics plc, has acquired common shares of the company. This information was published by Iterum Therapeutics via the EDGAR system on November 20, 2025. The news is generated by Public Technologies using AI and is for informational purposes only.</p>

Director Michael W. Dunne Acquires Common Shares of Iterum Therapeutics plc